Skip to Content

Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution

Last Updated: July 5, 2018
Status: Current

Products Affected - Description
    • Dorzolamide and Timolol ophthalmic solution, Akorn, 22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count, NDC 50383-0233-10
    • Dorzolamide and Timolol ophthalmic solution, Teva, 22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count, NDC 00591-2482-79
    • Dorzolamide and Timolol ophthalmic solution, Valeant, 22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count, NDC 24208-0486-10
Reason for the Shortage
    • Akorn has dorzolamide and timolol ophthalmic solution on shortage due to manufacturing delays.
    • Sandoz did not provide a reason for the shortage.
    • Teva discontinued dorzolamide and timolol ophthalmic solution in April 2018.
    • Valeant has dorzolamide and timolol ophthalmic solution on shortage due to manufacturing delays.
Available Products
    • Cosopt ophthalmic solution, Akorn, 22.3 mg-6.8 mg/mL, 10 mL Ocumeter Plus bottle, 1 count, NDC 17478-0605-10
    • Cosopt PF ophthalmic solution, Akorn, 22.3 mg-6.8 mg/mL, 0.2 mL single-use preservative-free vial, 60 count, NDC 17478-0604-30
    • Dorzolamide and Timolol ophthalmic solution, Sandoz, 22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count, NDC 61314-0030-02

Estimated Resupply Dates

    • Akorn has dorzolamide 2% and timolol 0.5% ophthalmic solution in 10 mL bottles on allocation.
    • Valeant has dorzolamide 2% and timolol 0.5% ophthalmic solution in 10 mL bottles on back order and the company estimates a release date of early-August 2018.

Implications for Patient Care

    • Each product contains dorzolamide hydrochloride 22.3 mg/mL (equivalent to dorzolamide 2%) and timolol maleate 6.8 mg/mL (equivalent to timolol 0.5%).

Updated

Updated July 5, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 30, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide